Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
08/2002
08/08/2002WO2002061055A2 Methods for regulating the kinase domain of ephb2
08/08/2002WO2002061050A2 Methods for determining ring number in carotenoids by lycopene epsilon-cyclases and uses thereof
08/08/2002WO2002061034A2 Compositions and methods for rapidly generating recombinant nucleic acid molecules
08/08/2002WO2002060951A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
08/08/2002WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
08/08/2002WO2002060942A2 Protein modification and maintenance molecules
08/08/2002WO2002060940A1 Juvenile hormone esterase
08/08/2002WO2002060939A2 Method for increasing the sulphur-compound content in plants
08/08/2002WO2002060932A2 A serpin in bifidobacteria
08/08/2002WO2002060931A2 A fimbria-like gene in bifidobacteria
08/08/2002WO2002060927A1 Protein kinase signalling
08/08/2002WO2002060926A2 Hepatitis c tripeptide inhibitors
08/08/2002WO2002060915A1 Drug target isogenes: polymorphisms in the cytochrome p450, subfamily viia (cholesterol 7 alpha-monooxygenase), polypeptide 1 gene
08/08/2002WO2002060492A1 Methods of inhibiting kinases
08/08/2002WO2002060474A2 Mixtures of mushroom enzymes and the use thereof for treating maldigestion
08/08/2002WO2002060469A1 Anticancer agents
08/08/2002WO2002042441A3 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE
08/08/2002WO2002040516A3 Helicobacter cysteine rich protein a (hcpa) and uses thereof
08/08/2002WO2002034901A8 Protein kinase
08/08/2002WO2002024863A3 Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activity
08/08/2002WO2002020740A3 Proteolysis targeting chimeric pharmaceutical
08/08/2002WO2002020572A3 Nucleotide sequences coding for the chrs gene
08/08/2002WO2002018582A3 62112, a novel human dehydrogenase and uses thereof
08/08/2002WO2002018556A3 8797, a human galactosyltransferase and uses thereof
08/08/2002WO2002016397A3 Haplotypes of the lipg gene
08/08/2002WO2002008395A3 Putative human methyltransferase family member and uses thereof
08/08/2002WO2002004614A3 Genes encoding sinapoylglucose: malate sinapoyltransferase and methods of use
08/08/2002WO2002000853A3 Regulation of human caspase-1-like protease
08/08/2002WO2002000840A3 Human lyases
08/08/2002WO2001098455A3 Method for preparing a physiologically active il-18 polypeptide
08/08/2002WO2001096546A3 Protein phosphatases
08/08/2002WO2001090330A3 AMINOACYL tRNA SYNTHETASES
08/08/2002WO2001083717A3 Designing modulators for alpha-1, 3 galactosyltransferases based on a structural model
08/08/2002WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec)
08/08/2002WO2001075435A3 Fluorescence assay for gamma-secretase activity and inhibitors
08/08/2002WO2001064905A3 2504, 15977, and 14760, novel protein kinase family members and uses therefor
08/08/2002WO2001059152A9 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
08/08/2002WO2001051641A9 Irak-4: compositions and methods of use
08/08/2002WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer
08/08/2002WO2001029146A9 Environmentally friendly de-icer and anti-icer compositions
08/08/2002WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use
08/08/2002WO2000073510A9 iETHOD OF TRANSPOSON-MEDIATED MUTAGENESIS IN THE NEMATODE CAENORHABDITIS ELEGANS
08/08/2002WO2000048703A9 Purification of biological substances
08/08/2002US20020108151 Regulation of quinolate phosphoribosyl transferase expression
08/08/2002US20020108149 Methods of increasing polypeptide accumulation in plants
08/08/2002US20020108148 Nucleic acid sequences to proteins involved in isoprenoid synthesis
08/08/2002US20020108147 Nucleotide sequences coding enzymatic polypeptide for use in the generation of gamma linolenic acid
08/08/2002US20020108145 Polypeptide for use in inducing diseases resistance in plants
08/08/2002US20020108143 Theobromine synthase polypeptide of coffee plant and the gene encoding said polypeptide
08/08/2002US20020108139 Production of a plant resistant to low temperatures
08/08/2002US20020108136 Animal models for use as tools in the treatment of genetic disorders
08/08/2002US20020108133 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
08/08/2002US20020107387 Nucleotide sequences coding envelope protein for use in prevention of viral disease and parasitic infections
08/08/2002US20020107384 Novel human kinase and polynucleotides encoding the same
08/08/2002US20020107383 Guanosine diphosphate activation protein; for use in the of genetic disorders and cancer
08/08/2002US20020107381 Nucleotide sequences coding enzymatic polypeptides for use in the treatment and prevention of diabetes, dietetics, sex disorders and infection
08/08/2002US20020107379 Nucleotide sequences coding for the thyA gene
08/08/2002US20020107376 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of liver disorders and cancer
08/08/2002US20020107374 Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods
08/08/2002US20020107362 Novel fluorescent proteins
08/08/2002US20020107361 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same
08/08/2002US20020107271 Heterocyclic aromatic oxazole compounds and use thereof
08/08/2002US20020107270 Selective inhibitory action on cyclooxygenase- 2 and are expected to be useful as anti-inflammatory agents with less side-effects such as digestive tract disorders.
08/08/2002US20020107218 Using inhibitors such as antisense nucleic acids
08/08/2002US20020107216 Antisense oligonucleotides complementary to Integrin-linked kinase (ILK)
08/08/2002US20020107214 Using chimeric restriction endonucleases; treating or prophylaxis of a genetic disease
08/08/2002US20020107192 Isolated 23686 proteins, fusion proteins, antigenic peptides and anti-23686 antibodies and diagnostic methods utilizing said
08/08/2002US20020107189 FK506 binding proteins (FKBPs); rapamysin derivatives; multimerizing chimeric proteins in genetically engineered cells using said derivatives
08/08/2002US20020107186 Isolated NOVX polynucleotides and polypeptides encoded by them
08/08/2002US20020107181 Novel hepatitis C virus ("HCV") protease inhibitors and pharmaceutical compositions comprising them optionally with viricide ribavirin and interferon
08/08/2002US20020107177 And methods for identifying Factor XIIIa inhibitors by contacting chemical in question with lipoprotein(a) component, a matrix component, and Factor XIIIa; complex formation inhibition indicates activity
08/08/2002US20020107170 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
08/08/2002US20020106794 Purifying dopamine cells; obtain cells, transfect with vector coding fluorescent molecules, detect fluorescent cells, recover fluorscent cells
08/08/2002US20020106782 Protein having glutaminase activity and gene encoding the same
08/08/2002US20020106781 Mammalian TNF-alpha convertases
08/08/2002US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies
08/08/2002US20020106779 Thermostable peptidase
08/08/2002US20020106776 pth
08/08/2002US20020106775 Nuclelotide sequences coding enzymatic polypeptide for use reating tumors allows experimental determination of protein structures at the atomic level and integration of these protein structures into
08/08/2002US20020106774 Nucleotide sequences coding enzymatic polypeptide for use in treatment and diagnosis of cell proliferative and/ differentiative, bone, immune, hematopoietic, cardiovascular disorders and liver disorders viral diseases and pain
08/08/2002US20020106773 Protein-protein interactions in neurodegenerative diseases
08/08/2002US20020106772 Geranyl diphosphate synthase large subunit, and methods of use
08/08/2002US20020106771 Nucleic acids encoding CLK protein kinases
08/08/2002US20020106770 25233, a novel human aminotransferase and uses therefor
08/08/2002US20020106769 UDP-D-glucose: limonoid glucosyltransferase
08/08/2002US20020106763 Process for preparing optically active 3-hydroxy-pyrrolidine derivatives by enzymatic hydroxylation
08/08/2002US20020106758 Polynucleotide sequence which codes enzymatic polypeptide for use in the generation of preferential amino acids, for use in human medicine, foods and animal feeds
08/08/2002US20020106754 Polynucleotide which codes prefrential polypeptide for use in the preparation alanine and lysine for human medicine, foods and animal nutrients
08/08/2002US20020106753 L-amino acid oxidase from Rhodococcus species
08/08/2002US20020106752 Racemization of N-carbamoyl amino acids; obtain sample of n-carbamoyl amino acids, incubate with racemase, recover enantimorph
08/08/2002US20020106750 Polynucleotides which code enzymatic polypeptide for use in the fermentation of amino acids, for use in human medicine, foods and animal nutrients
08/08/2002US20020106748 Polynucleotide which code enzymatic polypetide for use in genration of lysine
08/08/2002US20020106747 Esterified polysaccharide products and beta-lactone ring opened ketene dimer products containing the compositions, and process of making the same
08/08/2002US20020106733 Polypeptide for use in the treatment of disorders associated with diabetes and dietetics
08/08/2002US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
08/08/2002US20020106726 Peptide for use in the treatment of inflammation defects
08/08/2002US20020106725 Generating preferential enzymatic polypeptide for use in foods, animal feed, pharmacology, and dentistry
08/08/2002US20020106713 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
08/08/2002US20020106704 Human goose-type lysozyme
08/08/2002US20020106689 Detecting immunological defects in mammal; obtain sample tissue from mammal, detect proteasome activity, reduction in proteasome activty indicates immunological defect